Assertion Supported AI assessment confidence: 95% certainty 4/5 debate potential 3/5

Israel says vaping illnesses stem from black-market THC, not nicotine vapes

Josh Israel · #79 The Anti-JUUL · Mar 3, 2025 · at 19:30

Josh Israel, founder of smoking cessation startup Hava Health, addresses the 2019 vaping health crisis during an update interview on The Pitch.

0:00 / 0:14exact quote · 15.0s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“If you look at nicotine-based vapes, there hasn't been any directly related health crisis or crises that have sprung up because of them. It's all been linked to THC and vitamin E or vitamin A acetate and the THC kind of black market pods.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Josh Israel

Assertion Supported
Israel says nicotine patch and gum success rates are 5% to 15%
“Like, if you look at the success rates for the patch of the gum, it's five to 15%. People try seven to eight times with those products on average to quit. They don't work.”
Josh Israel Mar 3, 2025 ▶ 4:48 #79 The Anti-JUUL
Prediction Open · timeframe Mar 2028
Israel expects Hava Health's time to market to be 36 months
“So total time to market, estimating around 36 months.”
Josh Israel Mar 3, 2025 ▶ 9:28 #79 The Anti-JUUL
Disclosure
Israel says Hava is contractually committed against taking Big Tobacco capital
“What we did in his advisory agreement, you know, we made it explicitly clear that we're a smoking cessation product and we will never take capital from big tobacco.”
Josh Israel Mar 3, 2025 ▶ 14:40 #79 The Anti-JUUL
Assertion Supported
Israel says pre-2016 vape makers like Juul launched with zero FDA testing
“They haven't done any tests at all. It was like a pretty much a free for all pre-two 1016 where anybody could release a product and they were grandfathered in.”
Josh Israel Mar 3, 2025 ▶ 20:20 #79 The Anti-JUUL
Disclosure
Israel says Hava closed $1M pre-seed and seeks $250K oversubscription
“I'm happy to say that we recently closed our pre-seed round of one million dollars, so I'm here today to look at potentially oversubscribing that round with investments up to 250,000 dollars to further product development while we go through our preclinical ph…”
Josh Israel Mar 3, 2025 ▶ 3:38 #79 The Anti-JUUL
Prediction Not checkable as stated
Israel expects $375 revenue per customer based on 12-month retention
“On average, about 12 months so we should get around 375 dollars per customer, and the cost to us is around 85 to 125 dollars.”
Josh Israel Mar 3, 2025 ▶ 7:16 #79 The Anti-JUUL
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.